Effective treatment of refractory acquired pure red blood cell aplasia with eltrombopag and sirolimus: a case report.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yuzhou,Huang

第一单位： Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

作者： Yuzhou,Huang ^[1] ; Xianyong,Jiang ^[1] ; Bing,Han ^[2]

作者单位： Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. ^[1] Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Shuaifuyuan No. 1, Dongcheng District, Beijing 100730, China. ^[2]

关键词 acquired pure red cell aplasia eltrombopag refractory sirolimus

DOI 10.1177/2040620720940144

PMID 32733663

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in hematology

2020年11卷

2040620720940144页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Effective treatment of refractory acquired pure red blood cell aplasia with eltrombopag and sirolimus: a case report.

Therapeutic advances in hematology

相似文献

Therapeutic advances in hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effective treatment of refractory acquired pure red blood cell aplasia with eltrombopag and sirolimus: a case report.

Therapeutic advances in hematology

相似文献

Therapeutic advances in hematology

相关期刊

检索历史清除